204 related articles for article (PubMed ID: 31200238)
1. Oridonin derivatives as potential anticancer drug candidates triggering apoptosis through mitochondrial pathway in the liver cancer cells.
Luo D; Yi Y; Peng K; Liu T; Yang J; Liu S; Zhao W; Qu X; Yu W; Gu Y; Wan S
Eur J Med Chem; 2019 Sep; 178():365-379. PubMed ID: 31200238
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, and evaluation of in vitro and in vivo anticancer activity of 14-substituted oridonin analogs: A novel and potent cell cycle arrest and apoptosis inducer through the p53-MDM2 pathway.
Shen QK; Deng H; Wang SB; Tian YS; Quan ZS
Eur J Med Chem; 2019 Jul; 173():15-31. PubMed ID: 30981113
[TBL] [Abstract][Full Text] [Related]
3. A Novel Potent Anticancer Compound Optimized from a Natural Oridonin Scaffold Induces Apoptosis and Cell Cycle Arrest through the Mitochondrial Pathway.
Xu S; Yao H; Luo S; Zhang YK; Yang DH; Li D; Wang G; Hu M; Qiu Y; Wu X; Yao H; Xie W; Chen ZS; Xu J
J Med Chem; 2017 Feb; 60(4):1449-1468. PubMed ID: 28165738
[TBL] [Abstract][Full Text] [Related]
4. Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies.
Xu S; Wang G; Lin Y; Zhang Y; Pei L; Yao H; Hu M; Qiu Y; Huang Z; Zhang Y; Xu J
Bioorg Med Chem Lett; 2016 Jun; 26(12):2795-2800. PubMed ID: 27158140
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of spirolactone-type diterpenoid derivatives from kaurene-type oridonin with improved antiproliferative effects and their apoptosis-inducing activity in human hepatoma Bel-7402 cells.
Li D; Cai H; Jiang B; Liu G; Wang Y; Wang L; Yao H; Wu X; Sun Y; Xu J
Eur J Med Chem; 2013 Jan; 59():322-8. PubMed ID: 23274570
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of Oridonin Derivatives via Mizoroki-Heck Reaction and Click Chemistry for Cytotoxic Activity.
Hou W; Fan Q; Su L; Xu H
Anticancer Agents Med Chem; 2019; 19(7):935-947. PubMed ID: 30657049
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulfide donating ent-kaurane and spirolactone-type 6,7-seco-ent-kaurane derivatives: Design, synthesis and antiproliferative properties.
Li H; Gao X; Huang X; Wang X; Xu S; Uchita T; Gao M; Xu J; Hua H; Li D
Eur J Med Chem; 2019 Sep; 178():446-457. PubMed ID: 31202992
[TBL] [Abstract][Full Text] [Related]
8. The conversion of oridonin to spirolactone-type or enmein-type diterpenoid: synthesis and biological evaluation of ent-6,7-seco-oridonin derivatives as novel potential anticancer agents.
Wang L; Li D; Xu S; Cai H; Yao H; Zhang Y; Jiang J; Xu J
Eur J Med Chem; 2012 Jun; 52():242-50. PubMed ID: 22483090
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of novel oridonin analogues as potent anticancer agents.
Shen QK; Chen ZA; Zhang HJ; Li JL; Liu CF; Gong GH; Quan ZS
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):324-333. PubMed ID: 29303372
[TBL] [Abstract][Full Text] [Related]
10. 6,7-Seco-ent-Kauranoids Derived from Oridonin as Potential Anticancer Agents.
Xu S; Yao H; Hu M; Li D; Zhu Z; Xie W; Yao H; Wu L; Chen ZS; Xu J
J Nat Prod; 2017 Sep; 80(9):2391-2398. PubMed ID: 28901767
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen sulfide releasing oridonin derivatives induce apoptosis through extrinsic and intrinsic pathways.
Li H; Mu J; Sun J; Xu S; Liu W; Xu F; Li Z; Xu J; Hua H; Li D
Eur J Med Chem; 2020 Feb; 187():111978. PubMed ID: 31877536
[TBL] [Abstract][Full Text] [Related]
12. Enmein-type diterpenoid analogs from natural kaurene-type oridonin: Synthesis and their antitumor biological evaluation.
Li D; Xu S; Cai H; Pei L; Zhang H; Wang L; Yao H; Wu X; Jiang J; Sun Y; Xu J
Eur J Med Chem; 2013 Jun; 64():215-21. PubMed ID: 23644204
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel Jiyuan Oridonin A-1,2,3-triazole-azole derivatives as antiproliferative agents.
Ke Y; Liang JJ; Hou RJ; Li MM; Zhao LF; Wang W; Liu Y; Xie H; Yang RH; Hu TX; Wang JY; Liu HM
Eur J Med Chem; 2018 Sep; 157():1249-1263. PubMed ID: 30193221
[TBL] [Abstract][Full Text] [Related]
14. Oridonin induces apoptosis and cell cycle arrest of gallbladder cancer cells via the mitochondrial pathway.
Bao R; Shu Y; Wu X; Weng H; Ding Q; Cao Y; Li M; Mu J; Wu W; Ding Q; Tan Z; Liu T; Jiang L; Hu Y; Gu J; Liu Y
BMC Cancer; 2014 Mar; 14():217. PubMed ID: 24655726
[TBL] [Abstract][Full Text] [Related]
15. Probing the Anticancer Action of Oridonin with Fluorescent Analogues: Visualizing Subcellular Localization to Mitochondria.
Xu S; Luo S; Yao H; Cai H; Miao X; Wu F; Yang DH; Wu X; Xie W; Yao H; Chen ZS; Xu J
J Med Chem; 2016 May; 59(10):5022-34. PubMed ID: 27089099
[TBL] [Abstract][Full Text] [Related]
16. Proteomic identification of proteins involved in the anticancer activities of oridonin in HepG2 cells.
Wang H; Ye Y; Pan SY; Zhu GY; Li YW; Fong DW; Yu ZL
Phytomedicine; 2011 Jan; 18(2-3):163-9. PubMed ID: 20724128
[TBL] [Abstract][Full Text] [Related]
17. Oridonin exerts anticancer effect on osteosarcoma by activating PPAR-γ and inhibiting Nrf2 pathway.
Lu Y; Sun Y; Zhu J; Yu L; Jiang X; Zhang J; Dong X; Ma B; Zhang Q
Cell Death Dis; 2018 Jan; 9(1):15. PubMed ID: 29323103
[TBL] [Abstract][Full Text] [Related]
18. Novel nitrogen-enriched oridonin analogues with thiazole-fused A-ring: protecting group-free synthesis, enhanced anticancer profile, and improved aqueous solubility.
Ding C; Zhang Y; Chen H; Yang Z; Wild C; Chu L; Liu H; Shen Q; Zhou J
J Med Chem; 2013 Jun; 56(12):5048-58. PubMed ID: 23746196
[TBL] [Abstract][Full Text] [Related]
19. Oridonin, a Promising ent-Kaurane Diterpenoid Lead Compound.
Li D; Han T; Liao J; Hu X; Xu S; Tian K; Gu X; Cheng K; Li Z; Hua H; Xu J
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563888
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Cytotoxicity Assessment of Novel 7-O- and 14-O-Derivatives of Glaucocalyxin A.
Liu HC; Qiao LM; Zheng W; Xiang ZB; Chen HS; Yu SC; Zhang DZ; Wang T; Zhang YF; Jin YS
Anticancer Agents Med Chem; 2020; 20(10):1241-1249. PubMed ID: 32116205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
